Fabio
3.9 KiB
3.9 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO INSURANCE DISCRIMINATION BASED ON PRE-EXPOSURE PROPHYLAXIS MEDICATION TO PREVENT HIV INFECTION. | Individuals who are at very high risk of getting HIV can take pre-exposure prophylaxis (“PrEP”) medication to reduce the risk of HIV transmission. PrEP medication reduces the risk of HIV transmission by up to 99% if taken daily. This Act prohibits discrimination because an individual takes PrEP medication in the issuance or renewal of disability, long-term care, and life insurance. | us/states/de | Delaware General Assembly | 151 | HB 111 | Delaware HB 111 (151) |
|
enacted |
|
1 | 8 | 2 | 2021-02-19 | 2021-06-15 | openstates | ocd-bill/1c2aaf3b-ce5f-47a1-9232-6a982715f567 | https://legis.delaware.gov/BillDetail?LegislationId=48388 | 8984416fbf4140a3c7beb465a42e37adea857d689ad4b6bb9729e8d3e770c326 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Delaware HB 111 (151) — AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO INSURANCE DISCRIMINATION BASED ON PRE-EXPOSURE PROPHYLAXIS MEDICATION TO PREVENT HIV INFECTION.
Individuals who are at very high risk of getting HIV can take pre-exposure prophylaxis (“PrEP”) medication to reduce the risk of HIV transmission. PrEP medication reduces the risk of HIV transmission by up to 99% if taken daily. This Act prohibits discrimination because an individual takes PrEP medication in the issuance or renewal of disability, long-term care, and life insurance.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Bill Text (committee substitute) — source
Votes
- SM — 21–0 (pass) · upper
- 2/3 — 41–0 (pass) · lower
Sponsors
- Bryan Townsend — primary (person)
- Debra Heffernan — primary (person)
- Eric Morrison — primary (person)
- Sarah McBride — primary (person)
- Sean M. Lynn — primary (person)
- David P. Sokola — cosponsor (person)
- John A. Kowalko — cosponsor (person)
- Kendra Johnson — cosponsor (person)
- Larry Lambert — cosponsor (person)
- Marie Pinkney — cosponsor (person)
- Paul S. Baumbach — cosponsor (person)
- Spiros Mantzavinos — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-02-19 Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
introduction, referral-committee - 2021-03-16 Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 4 Favorable, 5 On Its Merits
committee-passage, committee-passage-favorable - 2021-03-26 Suspension of Rules in House
- 2021-03-30 Passed By House. Votes: 41 YES
passage - 2021-03-30 Assigned to Banking, Business & Insurance Committee in Senate
introduction, referral-committee - 2021-05-13 Reported Out of Committee (Banking, Business & Insurance) in Senate with 5 On Its Merits
committee-passage - 2021-05-19 Passed By Senate. Votes: 21 YES
passage - 2021-06-15 Signed by Governor
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/1c2aaf3b-ce5f-47a1-9232-6a982715f567. Confidence: reported (aggregated from official Delaware legislature records).